Padcev, a drug Pfizer acquired in 2023, is a part of the only chemo-free treatment for bladder cancer patients newly ...

Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

Is Pfizer stock a sell after shares skidded on the news Trump selected Kennedy to take over HHS? Is PFE stock now a sell?

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

Stocks knocked down in the first ten months of the year often suffer further damage as people sell for tax losses. But they ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...

Moderna stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and ...

On Thursday, Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $25.13 which represents a slight increase of $0.19 or 0.76% from the prior close of $24.94. The stock opened at $24.87 and ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But the ...